EPTRI General Assembly and Scientific Meeting 2024

Home / Media / Events / EPTRI General Assembly and Scientific Meeting 2024

EPTRI Scientific Meeting 2024

We are happy to announce our General Assembly and Scientific Meeting that will be held on 18 and 19 of July in Bari, Italy.

At this event we will discuss the latest news on the development and advancement of new therapeutic options for the paediatric population.

We look forward to seeing you at this exciting event.

Call for abstract

We have launched a call for abstracts for the EPTRI Scientific Meeting 2024 to select abstracts for oral presentations on several topics related to the five Thematic Research Platform of EPTRI.

We encourage researchers, companies, agencies, patient groups, health care professionals and all other interested parties to submit an abstract to the EPTRI Scientific Meeting.

Important Dates for Abstract Submission

  • Deadline for Abstract Submission: 31/05/2024
  • Notification of Abstract Acceptance: 15/06/2024
  • Registration of the presenting author is mandatory to all accepted abstracts. Registration deadline for presenting authors is 25/06/2024. Only registered authors will have their abstracts published in the online “Book of Abstracts” of EPTRI.


Abstract submission

To submit your abstract please fill in the Abstract Submission Form.  Authors can submit a maximum of three abstracts but can be the presenting author of only one. All abstracts must be submitted in English only. Please do not submit multiple copies of the same abstract.

Please contact the Organizing Secretariat ([email protected]) if you need any further information regarding the meeting.

The accepted abstract from registered presenting authors will be published in the “Book of Abstracts” of the Thematic Scientific Meeting 2024 which will be available online on the EPTRI official website at www.eptri.eu.

Topics for oral presentations include:

  • Drug targets and assays methods for paediatric medicine
  • Bioinformatics in paediatric drug design
  • Advanced cellular/in vitro models for paediatric diseases
  • Identification / characterisation and validation of paediatric biomarkers
  • Biosample collection and paediatric biobanks
  • Microdosing and dosage adjustment in children/neonates
  • Alternative paediatric clinical studies (modelling and simulations, observational, secondary use, data sharing, etc)
  • Pharmacogenetics and other omics
  • Placenta physiology and pharmacology
  • Fetal and neonatal normal and pathological development
  • Paediatric formulation and preformulation
  • Patient experience (taste improvement)
  • Patients’ contribution in research that underpin clinical studies
  • Formulating delivery systems for biologics
  • Medical devices for paediatric subjects


Author guidelines

When submitting your abstract, please follow the guidelines given below:

  • Submitter’s contact details (Full first and family name(s), email, phone number, country)
  • Presenting author’s and co-Authors’ details (Full first and family name(s), affiliations)
  • Affiliation details: Institution/Company/University/Hospital/Department, City, Country
  • Abstract topic: please choose from the list of topics
  • Abstract title: please add the title in the abstract form
  • Abstract text: please fill the abstract form and keep in mind that the abstract should not exceed 4000 characters with spaces
  • Tables and Figures should not be included.
  • Keywords: up to 5 keywords may be provided (at least 1 keyword is required to go ahead with the submission)


Abstract acceptance criteria

Abstract will be accepted and scored using the following criteria:

Relevance of the topic for paediatric medicines discovery, biomarkers identification/validation, developmental pharmacology, formulations, and medical devices. Its innovation (how new/recent/up to date the information/study is) and practical application to the field.

Quality of content

  • Clarity of the title
  • Concision, coherence, and clarity of content (summary of purpose, methodology, results, conclusions, next steps/practical application, etc.)
  • Originality


Confirmation of receipt & notification of decision

You will receive email confirmation that your abstract has been received, indicating the allocated abstract number. Please refer to this abstract number in all further correspondence regarding the abstract. Please contact [email protected] if you submit an abstract and do not receive confirmation that it has been received. Only the submitter will receive all information concerning the abstract. Authors will be notified about results by 15/06/2024. Registration of the presenting authors before 25/06/2024 is mandatory for accepted abstracts. Only abstracts from registered presenting authors will be included in the program and published in the online “Book of Abstracts” of the Thematic Scientific Meeting 2024.

Copyright & Legal Obligation

All information in the abstract submission, including authors’ names, affiliations, and the content of abstract, will be used in the meeting publications and published on the EPTRI website at www.eptri.eu. The contributor carries legal obligations of the abstract; any violation to a third party’s rights will be the responsibility of the contributor him/herself.